p38a protein, a key enzyme in the regulation of various cellular functions, plays a crucial role in some diseases, including cancer, chronic inflammation, and neurodegenerative conditions.
Regeneron’s $500M fund spotlights corporate venture’s influential role in biotech
When Regeneron announced a $500 million corporate venture capital fund last week, it was the first time in years that a storied large pharma had
April 23, 2024